Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Shelter Pharma Ltd will conduct an investor conference call on June 19, 2026, at 4 PM IST. The call will discuss the company's audited financial results for H2 and the full year of FY2026, along with business and operational updates.
Jun 15 2026 18:57:08
Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015-
Completion And Commencement Of Dispatch Of Export Order
Shelter Pharma completed manufacturing and commenced dispatch of a USD 141,600 export order for Joemega Capsules from Taha Drugs & Chemicals. Products worth USD 118,634 have been dispatched to Sudan.
Jun 08 2026 19:06:16
Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015- Receipt Of Good Manufacturing Practices Certificate
Shelter Pharma announced the receipt of a Good Manufacturing Practices (GMP) Certificate from the Food & Drugs Control Administration, Gujarat State. This certification, valid until October 2030, confirms the company's compliance with manufacturing standards for Ayurvedic products, ensuring uninterrupted operations.
Jun 03 2026 11:47:43
Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015-Receipt Of Renewal Manufacturing Licence
Shelter Pharma has secured the renewal of its manufacturing license (Form 25D) from Gujarat's Food & Drugs Control Administration (Ayurved). This license is crucial for manufacturing Ayurvedic products and is valid until September 2030, ensuring continued business operations.
Jun 02 2026 14:40:23
Shelter Pharma Ltd - 543963 - Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Shelter Pharma has confirmed that there was no deviation or variation in the utilization of proceeds from its Preferential Issue of Convertible Warrants. The Rs.25.31 crore raised was used for working capital requirements as approved in the July 2025 EGM, demonstrating compliance.
May 28 2026 17:24:16
Shelter Pharma Ltd - 543963 - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Audited Standalone Financial Results For The Half Year And
Year Ended March 31, 2026.
Shelter Pharma declared audited FY26 financial results, with net profit increasing 24.73% YoY to ₹902.72 lakhs and revenue growing 44.38% YoY to ₹7,313.36 lakhs. M/S. I I Lakhani & Co. were reappointed as internal auditors for FY27.
May 28 2026 16:39:07
Shelter Pharma Ltd - 543963 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 28Th May, 2026
Shelter Pharma's Board will convene on May 28, 2026, to consider and approve the audited financial results for the half year and full year ended March 31, 2026. This meeting is crucial for investor insights into the company's annual performance.
May 22 2026 17:17:02
Read More